Erin Davis calls it the “SuperDuperPOD.” That’s two things in one name: pharmaceutical giant Bristol Myers Squibb (BMS) already runs one of the largest AI clusters in life sciences, with serious results to show for it. A…
Erin Davis calls it the “SuperDuperPOD.” That’s two things in one name: pharmaceutical giant Bristol Myers Squibb (BMS) already runs one of the largest AI clusters in life sciences, with serious results to show for it. A…
Erin Davis calls it the “SuperDuperPOD.” That’s two things in one name: pharmaceutical giant Bristol Myers Squibb (BMS) already runs one of the largest AI clusters in life sciences, with serious results to show for it. A…
Erin Davis calls it the “SuperDuperPOD.” That’s two things in one name: pharmaceutical giant Bristol Myers Squibb (BMS) already runs one of the largest AI clusters in life sciences, with serious results to show for it. A…
Erin Davis calls it the “SuperDuperPOD.” That’s two things in one name: pharmaceutical giant Bristol Myers Squibb (BMS) already runs one of the largest AI clusters in life sciences, with serious results to show for it. A…
Erin Davis calls it the “SuperDuperPOD.” That’s two things in one name: pharmaceutical giant Bristol Myers Squibb (BMS) already runs one of the largest AI clusters in life sciences, with serious results to show for it. A…
Erin Davis calls it the “SuperDuperPOD.” That’s two things in one name: pharmaceutical giant Bristol Myers Squibb (BMS) already runs one of the largest AI clusters in life sciences, with serious results to show for it. A…
Alex Chou: Correct. PCIe Gen7 is already in active development. The current plan is to have internal samples in 2H, 2027 and to move toward production in that same general timeframe.
Alex Chou: Correct. PCIe Gen7 is already in active development. The current plan is to have internal samples in 2H, 2027 and to move toward production in that same general timeframe.
Alex Chou: Correct. PCIe Gen7 is already in active development. The current plan is to have internal samples in 2H, 2027 and to move toward production in that same general timeframe.